Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

37.87
+3.068.79%
Post-market: 37.78-0.0900-0.24%19:58 EDT
Volume:5.58M
Turnover:207.09M
Market Cap:4.38B
PE:-9.10
High:38.08
Open:35.63
Low:35.03
Close:34.81
52wk High:43.15
52wk Low:22.96
Shares:115.55M
Float Shares:110.00M
Volume Ratio:1.72
T/O Rate:5.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1600
EPS(LYR):-3.1920
ROE:-70.04%
ROA:-42.54%
PB:8.72
PE(LYR):-11.86

Loading ...

Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Correspondence

Form CORRESP - Correspondence
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Proposed Sale Of Securities

Form 144 | VIKING THERAPEUTICS, INC. Director Lawson Macartney proposes to sell 2000 shares, with a total value of approximately $137,334.
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Oct 28, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Officer Greg Zante proposes to sell 131,687 Shares, with a total value of approximately $10.28 Million.
Oct 25, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Director Rouan Sarah Kathryn proposes to sell 11,000 shares, with a total value of approximately $889,430.
Oct 25, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Director Singleton proposes to sell 16000 shares, with a total value of approximately $1.27 Million.
Oct 23, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]